title: CpG promoter methylation status is not a prognostic indicator of gene expression in beryllium challenge.
abstract: Individuals exposed to beryllium (Be) may develop Be sensitization (BeS) and progress to chronic beryllium disease (CBD). Recent studies with other metal antigens suggest epigenetic mechanisms may be involved in inflammatory disease processes, including granulomatous lung disorders and that a number of metal cations alter gene methylation. The objective of this study was to determine if Be can exert an epigenetic effect on gene expression by altering methylation in the promoter region of specific genes known to be involved in Be antigen-mediated gene expression. To investigate this objective, three macrophage tumor mouse cell lines known to differentially produce tumor necrosis factor (TNF)-α, but not interferon (IFN)-γ, in response to Be antigen were cultured with Be or controls. Following challenges, ELISA were performed to quantify induced TNFα and IFNγ expression. Bisulfate-converted DNA was evaluated by pyrosequencing to quantify CpG methylation within the promoters of TNFα and IFNγ. Be-challenged H36.12J cells expressed higher levels of TNFα compared to either H36.12E cells or P388D.1 cells. However, there were no variations in TNFα promoter CpG methylation levels between cell lines at the six CpG sites tested. H36.12J cell TNFα expression was shown to be metal-specific by the induction of significantly more TNFα when exposed to Be than when exposed to aluminum sulfate, or nickel (II) chloride, but not when exposed to cobalt (II) chloride. However, H36.12J cell methylation levels at the six CpG sites examined in the TNFα promoter did not correlate with cytokine expression differences. Nonetheless, all three cell lines had significantly more promoter methylation at the six CpG sites investigated within the IFNγ promoter (a gene that is not expressed) when compared to the six CpG sites investigated in the TNFα promoter, regardless of treatment condition (p < 1.17 × 10(-9)). These findings suggest that, in this cell system, promoter hypo-methylation may be necessary to allow expression of metal-induced TNFα and that promoter hyper-methylation in the IFNγ promoter may interfere with expression. Also, at the dozen CpG sites investigated in the promoter regions of both genes, beryllium had no impact on promoter methylation status, despite its ability to induce pro-inflammatory cytokine expression.
authors.affiliation: a Division of Allergy and Clinical Immunology, Department of Medicine , School of Medicine , Aurora , CO , USA ;|b Center for Health, Work and Environment, Department of Environmental and Occupational Health , Colorado School of Public Health , Aurora , CO , USA.
authors.forename: Brian C
authors.initials: BC
authors.lastname: Tooker
authors.affiliation: a Division of Allergy and Clinical Immunology, Department of Medicine , School of Medicine , Aurora , CO , USA ;
authors.forename: Katherine
authors.initials: K
authors.lastname: Ozawa
authors.affiliation: a Division of Allergy and Clinical Immunology, Department of Medicine , School of Medicine , Aurora , CO , USA ;|b Center for Health, Work and Environment, Department of Environmental and Occupational Health , Colorado School of Public Health , Aurora , CO , USA.
authors.forename: Lee S
authors.initials: LS
authors.lastname: Newman
mesh_terms: D000818:Animals; D001607:Berylliosis / Q000175:diagnosis* / Q000276:immunology; D001608:Beryllium / Q000276:immunology* / Q000494:pharmacology; D002460:Cell Line; D002908:Chronic Disease; D018899:CpG Islands / Q000235:genetics*; D019175:DNA Methylation; D005786:Gene Expression Regulation; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D008168:Lung / Q000276:immunology*; D008262:Macrophage Activation; D008264:Macrophages / Q000187:drug effects / Q000276:immunology*; D051379:Mice; D011379:Prognosis; D011401:Promoter Regions, Genetic / Q000235:genetics*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma; D001608:Beryllium
keywords: Beryllium; CpG; DNA methylation; chronic beryllium disease; epigenetics; metal antigen